Caspase-1 (interleukin-1beta-converting enzyme) is inhibited by the human serpin analogue proteinase inhibitor 9
about
The serpin proteinase inhibitor 9 is an endogenous inhibitor of interleukin 1beta-converting enzyme (caspase-1) activity in human vascular smooth muscle cellsNucleocytoplasmic distribution of the ovalbumin serpin PI-9 requires a nonconventional nuclear import pathway and the export factor Crm1Induction of serine protease inhibitor 9 by Mycobacterium tuberculosis inhibits apoptosis and promotes survival of infected macrophagesInhibitory mechanism of a cross-class serpin, the squamous cell carcinoma antigen 1The squamous cell carcinoma antigen 2 inhibits the cysteine proteinase activity of a major mite allergen, Der p 1Serine proteinase inhibitor 9 can be recognized by cytotoxic T lymphocytes of epithelial cancer patientsGranzyme M is a regulatory protease that inactivates proteinase inhibitor 9, an endogenous inhibitor of granzyme BInflammasomes: caspase-1-activating platforms with critical roles in host defenseTranscriptional networks in plasmacytoid dendritic cells stimulated with synthetic TLR 7 agonistsNeutrophil elastase, proteinase 3, and cathepsin G as therapeutic targets in human diseases.Role of protease inhibitor 9 in survival and replication of Mycobacterium tuberculosis in mononuclear phagocytes from HIV-1-infected patientsSerine protease inhibitor 6 is required to protect dendritic cells from the kiss of deathStructural insights into the unique inhibitory mechanism of the silkworm protease inhibitor serpin18.The human serpin proteinase inhibitor-9 self-associates at physiological temperatures.Flightless-I regulates proinflammatory caspases by selectively modulating intracellular localization and caspase activity.Serine protease inhibitor 6 plays a critical role in protecting murine granzyme B-producing regulatory T cells.Human tissue factor pathway inhibitor-2 is internalized by cells and translocated to the nucleus by the importin system.Serpins in T cell immunity.Sustained inflammasome activity in macrophages impairs wound healing in type 2 diabetic humans and mice.Regulation of inflammasome activity.Serine protease inhibitors and cytotoxic T lymphocytes.The role of cysteine proteinases and their inhibitors in the host-pathogen cross talk.Evasion and interference: intracellular pathogens modulate caspase-dependent inflammatory responses.The hidden side of SERPINB1/Leukocyte Elastase Inhibitor.Serpins in arthropod biology.NF-kappaB protects from the lysosomal pathway of cell death.Reduced serpinB9-mediated caspase-1 inhibition can contribute to autoinflammatory disease.Inhibition of human initiator caspase 8 and effector caspase 3 by cross-class inhibitory bovSERPINA3-1 and A3-3.1.45 Å resolution structure of SRPN18 from the malaria vector Anopheles gambiae.The in situ up-regulation of chondrocyte interleukin-1-converting enzyme and interleukin-18 levels in experimental osteoarthritis is mediated by nitric oxide.Heparan sulfate inhibits inflammation and improves wound healing by downregulating the NLR family pyrin domain containing 3 (NLRP3) inflammasome in diabetic rats.Administration of 17β-Estradiol Improves Motoneuron Survival and Down-regulates Inflammasome Activation in Male SOD1(G93A) ALS Mice.
P2860
Q22254013-E990F789-4570-4EB6-BF73-982B2B524305Q24291464-DD6AD3F7-09DD-4907-8694-1A4289EF0F29Q24297607-1F7DF5E5-D27E-4051-A23F-DB6C41CB4F6BQ24318950-609FD259-194F-4588-A2CA-29F76B9BB1EFQ28186148-4507F353-0B72-4141-AE15-229083449AC4Q28202640-91F8EA99-F4F4-4751-950B-90C83B28B1CFQ28288671-0572D83E-2D82-4249-8783-4E39C181E445Q28389138-3B21C876-681B-4422-BECB-A236702B927AQ33302568-B80BC82A-77A9-4917-B40A-1CD93AECDE86Q34149948-B596F42A-4108-4390-8657-ECBA996BC65DQ35679772-43DD27C1-CEFC-4C20-ABF9-FA650BEBA115Q35724165-4A9498A3-FF53-44F4-A849-42A2EC9D46B1Q35824673-8CD9F74F-02AE-47DA-97A9-89C638591AA2Q36519309-916AD661-0A86-4F78-82FF-F06AF289B1C4Q36562930-8FC9D3AA-98AC-475E-996A-710B8C139570Q37112525-A3F1DFB3-8C54-4939-A809-53A0BB185ABFQ37152354-2AC6D9C8-EEF3-41C3-8F36-1A6F074206FDQ37222018-78F8C5C7-E60C-4E5F-A955-703C399D2D5BQ37597048-0E5AF68C-BC7E-409E-B294-18FD35F08903Q37750913-F377FDB2-2CD9-45EE-B316-13FA7EE588E2Q37763997-2197B85E-EFA4-4CDE-A657-A7DDF4E0B836Q38072995-24E1BAB2-C62E-4CE0-94EF-CB2B5C0A87B5Q38833342-627A5830-2278-4E77-A76D-9F68AAC2190CQ38898379-92DDB9BD-C9AC-49E9-98E7-4094F5867C01Q38948359-218D3A23-AACB-4FE3-ACDD-EB64E1F6F4D0Q39927881-7008D03C-94D6-4BEA-993C-CD4B8B3ABC9EQ41539053-EB93AD37-CA37-45CF-ADFA-81D74BEA428AQ43295977-5407DCCE-CDBD-477C-8D60-EC82249188FDQ44162108-E71C958B-24D5-4B0E-B38E-C702B5CD8B1DQ44183276-C1384C5B-64EB-4372-BD5E-F84E052464E2Q47368563-743E9E05-5E03-4F5E-8D29-E571BAB35303Q48161670-D1215507-A38D-406E-994F-4A7EA499B52D
P2860
Caspase-1 (interleukin-1beta-converting enzyme) is inhibited by the human serpin analogue proteinase inhibitor 9
description
1999 nî lūn-bûn
@nan
1999 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Caspase-1 (interleukin-1beta-c ...... nalogue proteinase inhibitor 9
@ast
Caspase-1 (interleukin-1beta-c ...... nalogue proteinase inhibitor 9
@en
Caspase-1 (interleukin-1beta-c ...... nalogue proteinase inhibitor 9
@en-gb
Caspase-1 (interleukin-1beta-c ...... nalogue proteinase inhibitor 9
@nl
type
label
Caspase-1 (interleukin-1beta-c ...... nalogue proteinase inhibitor 9
@ast
Caspase-1 (interleukin-1beta-c ...... nalogue proteinase inhibitor 9
@en
Caspase-1 (interleukin-1beta-c ...... nalogue proteinase inhibitor 9
@en-gb
Caspase-1 (interleukin-1beta-c ...... nalogue proteinase inhibitor 9
@nl
prefLabel
Caspase-1 (interleukin-1beta-c ...... nalogue proteinase inhibitor 9
@ast
Caspase-1 (interleukin-1beta-c ...... nalogue proteinase inhibitor 9
@en
Caspase-1 (interleukin-1beta-c ...... nalogue proteinase inhibitor 9
@en-gb
Caspase-1 (interleukin-1beta-c ...... nalogue proteinase inhibitor 9
@nl
P2093
P2860
P356
P1433
P1476
Caspase-1 (interleukin-1beta-c ...... nalogue proteinase inhibitor 9
@en
P2093
C A Sprecher
D A Giegel
D C Foster
J A Mankovich
J R Dahlen
R R Annand
R V Talanian
P2860
P304
P356
10.1042/BJ3420655
P407
P478
P577
1999-09-15T00:00:00Z